Eurofins Scientific 

As a prominent Contract Development & Manufacturing Organization (CDMO), Eurofins offers a powerful network of companies that provide comprehensive, end-to-end solutions for preclinical and clinical outsourcing services. We specialize in both Drug Substance / API and Drug Product development for Biologics and Small Molecules, helping (bio)pharmaceutical companies swiftly progress from the research phase to the clinical stages. At Eurofins CDMO, we pride ourselves on delivering integrated services that compress timelines to market, accelerating the drug development process. With facilities strategically located across North America, Europe, and India, we are well-equipped to support your drug development initiatives on a global scale. Our medium-sized CDMO ensures personalized dedication to each client’s projects, while our extensive expertise in preclinical and clinical drug development and manufacturing ensures that your project is in capable hands.

CDMO Services: Analytical Services, API Biologics (Cell, Gene, Vaccine and Virus), API Biologics (Protein and Peptide), API Chemical, Clinical Dose, Clinical Packaging, Commercial Dose- Injectables, Commercial Dose- Non Sterile, Commercial Dose- Solid Dose, Commercial Packaging

Year Founded: 1987

Head Office: Luxembourg

Number of Facilities: 59

Facility locations: Europe, Asia, America

Website: Visit Eurofins Scientific website

Linkedin: Connect on linkedin